Cargando…
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
BACKGROUND: Microsatellite instability (MSI) is now being used as a sole biomarker to guide immunotherapy treatment for men with advanced prostate cancer. Yet current molecular diagnostic tests for MSI have not been evaluated for use in prostate cancer. METHODS: We evaluated two next-generation sequ...
Autores principales: | Hempelmann, Jennifer A., Lockwood, Christina M., Konnick, Eric Q., Schweizer, Michael T., Antonarakis, Emmanuel S., Lotan, Tamara L., Montgomery, Bruce, Nelson, Peter S., Klemfuss, Nola, Salipante, Stephen J., Pritchard, Colin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904988/ https://www.ncbi.nlm.nih.gov/pubmed/29665853 http://dx.doi.org/10.1186/s40425-018-0341-y |
Ejemplares similares
-
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference
por: Jensen, Kendal, et al.
Publicado: (2020) -
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
por: Schweizer, Michael T., et al.
Publicado: (2016) -
Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations
por: Kuo, Ayako J., et al.
Publicado: (2020) -
Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
por: Konnick, Eric Q., et al.
Publicado: (2016) -
Applicability of Next Generation Sequencing Technology in Microsatellite Instability Testing
por: Gan, Chun, et al.
Publicado: (2015)